North Macedonia vs Qatar: Access to anti-retroviral drugs, female
North Macedonia
49.0%
in 2024
Qatar
43.0%
in 2024
North Macedonia rank
123rd
Qatar rank
126th
Access to anti-retroviral drugs, female over time
- North Macedonia
- Qatar
How they compare
North Macedonia currently reports 49.0% against 43.0% in Qatar, a difference of 6.0%.
That makes North Macedonia's figure about 1.1 times Qatar's.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was North Macedonia ahead.
North Macedonia ranks 123rd and Qatar ranks 126th of 141 countries.
Across the 3 decades both report, North Macedonia averaged higher in 1 and Qatar in 2.
Head to head by decade
| Decade | North Macedonia | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.6% | 0.0% | 14.6% | North Macedonia |
| 2010s | 45.8% | 85.2% | 39.4% | Qatar |
| 2020s | 46.2% | 53.0% | 6.8% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, North Macedonia or Qatar?
- North Macedonia, at 49.0% against 43.0% in Qatar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between North Macedonia and Qatar?
- 6.0%, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do North Macedonia and Qatar rank globally for access to anti-retroviral drugs, female?
- North Macedonia ranks 123rd and Qatar ranks 126th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.